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Introduction
 Depression, anxiety and Type 1 Diabetes Mellitus (Type 1 DM) are 
frequently comorbid and this can significantly affect quality of life, 
glycaemic control, and other acute and chronic diabetes complications 
[1]. Depressive disorders have been found in more than one third of 
people with diabetes, and their treatment would improve the quality 
of life and health of people with Type 1 DM [2,3]. Anxiety, which is 
often comorbid with depression, is also more common in people with 
Type 1 DM compared to those without diabetes [4]. Comorbid 
depression or anxiety can increase challenges of self-management 
and are barriers to reaching treatment goals [5]. Moreover, the 
combination of depression with another chronic condition results 
in the largest decrement in overall health of any comorbidity 
combination [6]. This means that for people with Type 1 DM, having 
comorbid depression could be the most significant barrier to 
reaching optimal self-care. The significance of these negative 
implications is the resultant substantial healthcare costs, which 
account for over $3 billion dollars annually in Australia [7]. Despite 
the significant burden that these conditions pose, comorbid 
depression and anxiety in diabetes is under-diagnosed and 
under-treated in Australia [8]. As a result numerous studies have 
been conducted to explore factors that may influence the association 
between these conditions.
 The psychological impact of living with a chronic condition as 
well as biological factors relating to neurotransmitter metabolism and 
changes to the hypothalamic-pituitary axis have been implicated in the 
pathophysiology of comorbid depression and diabetes [9,10]. Raised 
levels of inflammation from hyperactivity of the hypothalamic-pitu-
itary axis and insulin deficiency may underpin a biological dimension 
to this comorbidity in Type 1 DM [4]. Concomitant psycho-biological 
changes secondary to depressive disorders can decrease motivation 
and increase sedentary behaviour, which are known to contribute 
to sub-optimal self-management [11]. Living with the diagnosis of a 
chronic condition is also a risk factor for mental illness [12]. Type 1 
DM is a demanding condition that calls for persistent motivation and 
commitment even in the midst of competing life demands [13].
 One of the most common sources of concern for people is the 
bidirectional relationship that occurs between the symptoms of 
diabetes and psychological stress [8]. For example, when blood 
glucose fluctuates too high or too low it can cause alterations in mood 
and cognition [14]; similarly the opposite can occur, as blood glucose 
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Aim: To perform a review of studies to identify the prevalence of 
depression and anxiety in adults with Type 1 diabetes mellitus 
compared to adults without Type 1 diabetes mellitus.
Methods: A computer search was conducted using the PubMed, 
EBSCOhost, PsychINFO, Cochrane, CINAHL and MEDLINE 
from 2009 onwards. The essential information extracted from the 
identified publications were: participant demographics; 
measurement tools; prevalence of depression; diabetes-specific 
and non-diabetes specific risk and protective factors for depression 
or anxiety in people with Type 1 DM; outcomes for Type 1 DM 
management and complications; and relevant qualitative data.
Results: An extensive literature search identified twenty-one key 
articles which were reviewed to provide strong evidence further 
supporting the notion that there is increased prevalence of 
comorbid depression and anxiety in Type 1 DM. Based on the 
literature reviewed, approximately one in five people living with 
Type 1 DM suffer from comorbid clinical depression, and one in four 
experience anxiety. There was variation in the exact rates reported 
between articles, however, which may be reflective of differences in 
methods or samples.
Conclusion: The pertinence of the evidence analyzed in this review 
is underpinned by findings from large international studies that have 
shown depression results in worse health outcomes for individuals 
compared to any other chronic disease, including diabetes. Further, 
the combination of depression and diabetes leads to even poorer 
outcomes than does the combination of diabetes and other chronic 
diseases.
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can change in response to psychological stress often resulting in 
adjustments to insulin dose [15]. Key is that patients experiencing 
diabetes-distress and depressive symptoms experience difficulties in 
maintaining an effective management plan which has been linked to 
i) sub-optimal glycaemic control [16] and ii) higher incidence of 
diabetes-related complications [17]. Therefore psychological support 
is an essential component in holistic, multi-disciplinary diabetes care 
and should be considered a routine part of management [2,8,18].
 The crux of this issue lies within the unique challenge of diagnosing 
depression and anxiety in patients with chronic conditions. Patients 
with chronic conditions are generally less likely to be appropriately 
diagnosed with depression by their family doctor or their specialist 
than patients who do not have a chronic condition [19]. This could be 
due to a tendency to normalize psychological distress in the context of 
chronic conditions like Type 1 DM [20], especially when treatments 
are often perceived by healthcare professionals as being under-
standably burdensome to patients [8,11]. Increasing awareness and 
understanding of diabetes-specific stressors and common experiences 
can help differentiate ‘normal’ diabetes-related distress from 
pathological co morbid depression [21]. Past literature reviews have 
not included qualitative studies, however this data may provide 
essential insights [21,22] and help tailor diabetes-specific psych 
education, which is a key element in the treatment of depression and 
anxiety [18].
 The majority of reviews on depression and/or anxiety and diabetes 
have focused on Type 2 Diabetes Mellitus (Type 2 DM) [23]. Given 
the psychological, physical and socioeconomic impact of comorbid 
depression and diabetes, and considering the differences in the 
average age of onset, pathophysiology, and management between Type 
1 DM and Type 2 DM, the current review of the associated literature 
will focus on Type 1 DM. Furthermore, there have been few reviews 
that have considered the prevalence of anxiety in Type 1 DM, and as 
most studies have been conducted outside Australia it is also unclear 
to what extent evidence can be generalized to our local population.
Aim
 The aim of this review was to identify the prevalence, correlates 
and complications of depression and anxiety in adults with Type 1 DM 
compared to adults without Type 1 DM.
Methods
 A systematic electronic search was conducted to identify all 
relevant studies examining depression among adults with Type 1 
DM. Inclusion criteria were: (i) Adults aged 19 years and older; 
(ii) Studies that examined people with Type 1 DM; studies that 
included participants with Type 2 DM will be included if they 
adequately differentiate between the two groups in both their 
methods and results; (iii) Studies that assessed the effect of an 
intervention such as cognitive behavioural therapy or anti-depressant 
drugs will be included only if the effect of reducing depression or 
anxiety on diabetes (e.g., reducing complications or improving 
metabolic control) is measured; (iv) Type 1 DM was formally 
diagnosed in participants or clarified with reliable medical records 
and studies used standardized measure of depression with established 
reliability and validity; (v) comparison with an appropriate control 
group or population norms.
Exclusion criteria
 (i) literature reviews, case studies and qualitative research as these 
did not allow a prevalence rate of depression or the relationship 
between depressive symptoms and metabolic control to be extracted; 
(ii) Studies that include any participants under the age of 19 years; 
(iii) studies that only compared participants with Type 1 DM to those 
with Type 2 DM; (iv) studies where depression was defined simply as 
those who take antidepressants.
Search strategy
 A literature search was conducted between September and 
October 2013 on PubMed and EBSCOhost. The aim was to 
encapsulate as many relevant studies as possible, therefore 
relatively broad search terms were used. The searches were performed 
by searching MeSH term ‘type 1 diabetes’, with ‘depressive disorder’, 
‘anxiety’, ‘adjustment disorders’, and ‘distress’. The search was limited 
to show results that only included publications for the past five years, 
humans, adults (aged over 19 years), and studies published in the 
English language.
 A second literature search was conducted in February 2014 
(Figure 1), and in this instance PsychINFO, Cochrane, Pubmed, 
CINAHL and MEDLINE were used to ensure all relevant articles 
were captured Search terms were selected depending on the database, 
e.g., some databases had search headings that enabled researchers to 
specify specific disorders in the search, whereas others only allowed 
for the use of broad search headings such as ‘depression’ or ‘anxiety’. 
For Pubmed, Cochrane and MEDLINE, the MeSH terms ‘depression,’ 
‘depressive disorder, major,’ ‘dysthymic disorder,’ ‘depressive disorder, 
‘treatment resistant,’ ‘anxiety disorders,’ ‘adjustment disorders,’ were 
individually searched with the MeSH term ‘diabetes mellitus, type 1’ 
or titles including ‘type 1 AND diabetes.’ Separate searches for titles 
‘type 2 AND diabetes’, and ‘child* or adolescence*’ were conducted 
and their results excluded from the main search results. A limit for 
articles published from 2009 onwards was then applied.
Figure 1: Flow diagram of method used for database search in 2014.
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 A similar search was conducted on CINAHL using the CINAHL 
headings ‘adjustment disorders,’ ‘depression, reactive,’ ‘generalized 
anxiety disorder, ’ ‘anxiety disorders,’ ‘depression,’ or ‘anxiety,’ These 
results were narrowed by searching with the heading ‘diabetes 
mellitus, Type 1’ as well as the results from a title search for ‘Type 
1 AND diabetes’. These results were then further narrowed by 
excluding titles containing ‘type 2 AND diabetes’, or ‘child* or 
adolescence*’, and then limit of articles published from 2009 was 
applied. Thesaurus terms in PsychINFO selected were ‘dysthymic 
disorder’, ‘major depression’, ‘adjustment disorder’, ‘anxiety’, ‘anxiety 
disorder’, ‘depression (emotion)’, ‘atypical depression’, ‘recurrent 
depression,’ These results were then searched with the terms 
‘diabetes’ or ‘diabetes mellitus’ or titles including ‘type 1 AND 
diabetes.’ The results were similarly narrowed by excluding type 2 
diabetes, child* and adolescence* from the search, and a limit was 
applied to exclude articles published prior to 2009.
Data extraction and review
 Eligibility assessment was performed by a single reviewer. An 
initial screen of titles was performed, and then abstracts. Articles were 
excluded if they did not meet the eligibility criteria outlined in the 
study protocol. The remaining papers were then examined in closer 
detail and excluded if not all inclusion criteria were met, or if judged 
as having a high risk of bias. A tool for assessing bias was not suitable 
for use because many of the articles were observational studies, as such 
an alternative tailored approach was adopted [24]. Various approaches 
to quality assessment in observational studies have been used and 
although there is no ‘gold standard’, the development of 
content-specific assessment components is a viable recommended 
approach [25]. As such, individual components were chosen to 
highlight key factors in methodologies that may have contributed to 
bias (Table 1). Articles that fulfilled the requirements of a component 
are marked in the table with a tick and those that did not are marked 
with a cross. In some instances it was unclear from the study as to 
whether or not a criterion was met and in these instances ‘unclear’ 
was inserted.
 The essential information extracted from the identified 
publications were: participant demographics; measurement tools; 
prevalence of depression; diabetes-specific and non-diabetes specific 
risk and protective factors for depression or anxiety in people 
with Type 1 DM; outcomes for Type 1 DM management and 
complications; and relevant qualitative data.
 To calculate the average percentage prevalence of depression and 
anxiety reported by studies overall, percentage data from the articles 
that reported this finding were added and then divided by the total 
number included. For studies with more than one measure used and 
Study Sample size Measure of depression Total with depression (%)
Men with depression 
(% of men)
Women with depression 
(% of women)
Melin et al., 292 HADS score ≥ 8 30 (10%) 16 (10%) 14 (11%)
Maia et al., 100 with T1 DM (200 total) MINI; “current depression” 9 (9%) - -
van Bastelaar et al., 280 with T1 DM (627 total) CES - D 41 (15%) - -
Collins et al., 296 with T1 DM (1456 total) HADS score ≥ 8 60 (20%) 34 (23%)  26 (21%)
Ahola et al., 1266 BDI score ≥ 16 214 (17%) 78 (14%) 136 (20%)
Pouwer et al., 379 with T1 DM (722 total) WHO-5 ≤ 28 51 (13%) 18 (11%) 33 (16%)
 311 CES-D score ≥ 16 93 (30%) 33 (25%) 60 (33%)
 142† CIDI - major depressive disorder 11 (8%) 5 (8%) 6 (8%)
Gendelman et al., 458 with T1 DM) (1004 total) BDI score ≥ 14 -17% -14% -20%
  BDI score ≥ 14 or  antidepressant use (32%)*
‡ (26%)* -38%
Ruddock et al., 111 with T1 DM (211 total) HADS score ≥ 8 16 (14%) - -
Manarte & Dias 106 with T1 DM Hamilton score ≥ 7 57 (54%)   
Lloyd et al., 264 with T1 DM CES-D score ≥ 16 47 (18%) 14 (11%) 33 (25%)
  BDI score ≥ 16 35 (14%) 21 (16%) 14 (11%)
Hirai et al., 484 CES-D score ≥ 16 183 (38%) - -
Grant et al., 225 with T1 DM; non pump group (775 total)
Medical records and  
psychotropic use - 37% - -
Tanebaum & Gonzalez 34
Medical history of either past, 
current or recurrent major 
depressive disorder
15 (44%) - -
Hopkins et al., 484 HADS score ≥ 8 baseline (21%)α - -
  HADS ≥ 8 after DAFNE education (15%)
α - -
Speight et al., 1376 with T1 DM (3338 total) PHQ - 9 score ≥ 10 - 22% - -
Table 1: Prevalence of depression in adults with type 1 diabetes mellitus.
Centre for Epidemiologic Studies Depression Scale (CES-D): Beck Depression Inventory; Composite International Diagnostic Interview (CIDI); Hospital Anxiety 
Depression Scale (HADS); Mini International Neuropsychiatric Interview (MINI); Patient Health Questionnaire (PHQ-9); World Health Organisation (WHO-5);
*p<0.05 for men compared to women; †Only a selection of the sample were used for CIDI
‡Gendelman et al., reported that adults with Type 1 DM were twice as likely to be depressed than non-diabetic participants
αHopkins et al., found a significant improvement in HADS score for depression after DAFNE education programs compared to baseline levels
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Study N
Number 
with Type 
1 DM
Mean 
age 
(years)
Type 1 
DM mean 
duration 
(years)
Mean 
HbA1c 
(%)
Setting Country Selection Exclusion criteria for selection
Outcome measures and 
assessment
Melin et 
al., 292 292 41 21.1 8.3
Hospital 
outpatient 
clinic
Sweden
Patients selected 
from clinic during 
2009 by specialist 
nurse or physician.
Severe comor-
bidities (cancer, 
hepatic failure, 
end-stage renal 
disease, etc), 
severe psychiatric 
illness (severe 
psychosis, severe 
substance abuse, 
etc)
Depression and anxiety 
measured with HADS, 
with cut-off score of ≥ 8. 
HbA1c was performed 
in the clinic at time 
as HADS. Data was 
collected from medical 
records about diabetes 
complications.
Maia et 
al., 200 100 57.62 - -
Community 
outpatient 
clinic
Brazil
Patients recruited 
from clinic who 
had been already 
diagnosed with either 
Type 1 DM or Type 
2 DM.
Not specified
The MINI was used to 
assess each participant 
to screen for a range of 
psychiatric disorders.
van 
Bastelaar 
et al.,
627 280 44 22 7.8
Hospital 
outpatient 
clinic
Netherlands
Data about patients 
was taken from an-
other study (1) where 
people with Type 1 
DM and Type 2 DM 
were randomly sam-
pled from 3 diabetes 
clinics.
History of suicide, 
previous admis-
sion for depres-
sion, diagnosis of 
schizophrenia
HbA1c was recorded 
from most recent medical 
records. Depressive 
symptoms were mea-
sured with CES-D scale 
with a cut-off score of ≥ 
16. PAID score (problem 
areas in diabetes)
Sacco et 
al., 124 32 43.4 - 8.3
Community 
outpatient 
clinic
USA
Patients selected 
from a specialist dia-
betes outpatient clinic 
from waiting room or 
by telephone.
Not specified.
Depression assessed 
with Patient Health 
Questionnaire (PHQ-9). 
No cut-off score was 
specified by authors. 
HbA1c was obtained from 
medical records. 90% of 
values were taken within 
60 days prior to comple-
tion of questionnaires.
Bot et al., 642 277 43.9 22.1 7.8
Hospital 
outpatient 
clinic
Netherlands
Data about patients 
was taken from an-
other study (1) where 
people with Type 1 
DM and Type 2 DM 
were randomly sam-
pled from 3 diabetes 
clinics.
Not specified
Depressive symptoms as-
sessed with PHQ-9. Each 
symptom was assessed 
independently and 
considered significant if 
scored as being present 
‘nearly all the time’ or 
‘more than half the time.’ 
HbA1c was taken from 
medical records.
Ahola et 
al., 1226 1226 44.9 27 8
Hospital and 
community 
outpatient 
clinics
Finland
Patients were re-
cruited for FinnDiane 
study from hospitals 
and primary health 
care centers. All pa-
tients with Type1 DM 
at diabetic and renal 
clinics and dialysis 
units were asked to 
participate. Response 
rate 78%.
Patients with an 
age at diagnosis 
> 35 years or who 
had not had insulin 
therapy initiated 
within 1 year after 
diagnosis were 
excluded.
Depression assessed 
with the Beck inventory 
score (BDI) cut-off ≥ 16, 
or current use of an-
ti-depressants. Diabetic 
complications obtained 
from medical records.
Collins et 
al., 1456 296 - - -
Hospital and 
community 
outpatient 
clinics
Ireland
Patients from hospital 
and general practice 
settings were mailed 
surveys to complete 
and return.
Not specified
Depression and anxiety 
were assessed with 
HADS and cut-off points 
for mild (8-10), moderate 
(11-14) and severe (15-
21) were used.
Pouwer et 
al., 722 359 43 22 7.8
Hospital 
outpatient 
clinic
Netherlands
Data about patients 
was taken from a 
larger study (1) where 
people with Type 1 
DM and Type 2 DM 
were randomly sam-
pled from 3 diabetes 
clinics. 
Not specified
Depressive symptoms 
self-reported on WHO-5. 
Scores ≤ 28 are sugges-
tive of depression. CES-D 
scale also used with a 
cut-off of ≥ 16. WHO 
Composite International 
Diagnostic Interview 
(CIDI) also used to deter-
mine the presence of a 
mood disorder in the past 
12 months.
Citation: Subasinghe SS, Bongetti E, O’Brien CL, Silberberg C, Ward G, et al. (2015) A Review of the Prevalence and Associations of Depression and Anxiety in 
Type 1 Diabetes Mellitus. J Diabetes Metab Disord 2: 007.
• Page 5 of 11 •
J Diabetes Metab Disord ISSN: 2381-201X, Open Access Journal
DOI: 10.24966/DMD-201X/100007
Volume 2 • Issue 1 • 100007
Gendle-
man et 
al.,
1004 458 43.6 29.4 7.9
Community 
Outpatient 
clinic
USA
Patients were from 
another study (2) 
which recruited 
participants from the 
community.
Excluded if not 
diagnosed when < 
30 years old or not 
treated with insulin 
within 1 year of 
diagnosis
BDI-II was used with a 
cut-off of ≥ 14. Anti-de-
pressant medication use 
was also reported by 
patients and verified by 
researchers.
Shaban et 
al., 259 259 40 18 8.8
Hospital 
outpatient 
clinic
United King-
dom
Patients with Type 1 
DM were recruited 
from outpatient 
clinics.
If duration of Type 
1 DM < 1 year, 
not on flexible 
dose adjustment 
regimen
HADS was used to 
assess anxiety and de-
pression. A cut-off score 
was not specified. HbA1C 
within one month prior to 
questionnaire completion 
was recorded from medi-
cal records.
Ruddock 
et al., 211 111 44.9 23.1 7.9
Hospital 
outpatient 
clinic
United King-
dom
Patients from a dia-
betes outpatient clinic 
were invited by mail 
to participate.
Excluded if < 18 
years old, severe 
comorbidities, cog-
nitive or language 
deficits.
HADS with a score of ≥ 
8 was used to indicate 
either depression or 
anxiety symptoms.
Manarte & 
Dias 110 110 36.3 16.5 9.2
Community 
outpatient 
clinic
Portugal
Patients were recruit-
ed with surveys from 
waiting room over 3 
consecutive days.
Excluded if aged 
< 16 years, and 
didn’t speak Por-
tugese.
Hamilton scores of ≥ 7 
were used to suggest 
presence of depressive 
symptoms. Records of 
HbA1c within the last 3 
months were included. 
Number and types of 
complications from 
diabetes was also taken 
from records.
Lloyd et 
al., 264 264 45 36.7 7.5
Hospital 
outpatient 
clinic
United King-
dom
Data from the Pitts-
burgh Epidemiology 
of Diabetes Compli-
cations was used.
Excluded if not 
diagnosed before 
the age of 17 or 
not seen within a 
year of diagnosis 
at the Children’s 
Hospitals of 
Pittsburgh in 1950-
1980
BDI scores ≥ 16 and 
CES-D scores ≥ 16 were 
used to indicate the 
presence of depressive 
symptoms. Details about 
diabetes complications 
was retrieved from med-
ical files.
Hirai et 
al., 484 484 48.5 34.8 7.5 Community USA
484 participants with 
Type 1 DM who had 
participated in the 
Winconsin Epide-
miological Study of 
Diabetic retinopathy 
over a period of 25 
years.
Not specified
CES - D with cut-off ≥ 16 
was used as well as anti-
depressant use. Analysis 
that didn’t include those 
on antidepressants and 
only based on CES - D 
scores was also analysed 
for comparison to 
ensure that there was no 
difference in outcomes. 
Retinopathy diagnosed 
with fundoscopy.
Reichel et 
al., 52 52 41.4 20.9 7.16
Not spec-
ified
Germany Sample selection not 
specified
Not specified
HADS was used to as-
sess both depression and 
anxiety. Cut-off scores 
were not used although 
the authors refer to ‘mild’ 
and ‘severe’ depression 
and anxiety symptoms 
which the HADS has 
recommended scores 
for. Participants were 
all using a continuous 
subcutaneous insulin 
infusion pump so their di-
abetes had been clinically 
diagnosed.
Rasmus-
sen et al., 20 20 - - -
Hospital 
outpatient 
clinic
Australia
Patients recruited 
from a flyer in the city, 
a hospital outpatient 
clinic and support 
group website
Excluded if not 
between the ages 
of 18-38 years.
This was a qualitative 
study that assessed sig-
nificant transition stages 
in their lives and their 
main concerns living with 
diabetes.
Tane-
baum& 
Gonzalez
34 34 43.45 - 7.96
Hospital 
outpatient 
clinic
USA
Participants were 
recruited via 
direct referrals, clinic 
screenings, flyers.
None specified
Semi-structured 
interviews were used to 
assess for the presence 
of depressive symptoms 
and major depressive 
disorder. 
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therefore more than one percentage value the average of that study’s 
results was used.
Results and Discussion
 Between September and October 2013 234 articles were identified 
as being potentially relevant. Through a process of systematic 
exclusion, ten key papers were eventually identified and summarized 
(Figure 1).
 In the literature search conducted in February 2014 (Figure 1) 597 
articles were identified; 78 were duplicates and deleted and 454 were 
excluded on the basis of title and abstract.
Comparison of study designs
 There was variation in research design and methods as shown in 
table 2. Most studies used self-report scales to measure depression 
and anxiety, with only two studies opting for structured diagnostic 
interviews [26]. Two studies included qualitative data about 
experiences of people living with Type 1 DM [26,27].
 There was significant variation in sample size between studies 
(20-1456 participants). Some studies had mixed samples of Type 1 
DM and Type 2 DM however all papers in this review specified the 
number of participants who had Type 1 DM. Two studies were 
conducted in Australia [8,27] which may limit the degree to which 
this data can be generalized to our population.
 Two studies used the same samples from a larger study conducted 
in the Netherlands [5,14]. Therefore the data included from these in 
this review may over-represent this sample. The age of participants 
between studies is relatively comparable and ranges from 37 to 58, 
however not all included mean ages in their results [4,27]. There was 
some variation in the duration of diabetes (9.3 - 36.7 years) although 
five studies did not publish this data.
Assessment of risk of bias
 Results from an assessment of individual components relevant to 
risk of bias within studies are shown in table 3. Given that all studies 
were observational rather than randomized controlled trials, there 
is an inherent risk for bias within all of the studies reviewed [28], 
however this does not increase bias across studies.
The mongomery-asberg 
depression rating scale 
was used to evaluate 
severity of depressive 
symptoms. Participants 
also completed CES-D. 
Data was collected from 
previous visits about 
clinical assessments and 
HbA1c
Hopkins 
et al., 639 639 41.5 13.7 8.51
Not spec-
ified
United King-
dom
Retrospective study 
on patients who 
attended a DAFNE 
education session
Only those with 
follow-up data after 
DAFNE course 
were included 
in the analysis. 
These partici-
pants were older 
and had lower 
mean HbA1c% 
compared to those 
who did not have 
follow-up data.
Data was extracted from 
records collected by 31 
centres in the UK con-
ducted DAFNE courses 
about HbA1c and HADS 
at baseline and during a 
12 month follow up period 
after the DAFNE course. 
HADS cut-off score ≥ 8 
was used to assess both 
depression and anxiety.
Aberle et 
al., 51 51 36.5 19 7.1
Hospital 
Outpatient 
clinic
Germany
All patients attending 
a German diabetes 
centre who had Type 
1DM
None specified
Diabetes was diagnosed 
previously clinically. 
HbA1c was measured 
once consent to partic-
ipate was given. The 
German version of the 
self-rating depression 
scale was used to assess 
for the presence of 
depressive symptoms. 
Other psychological fac-
tors including self-efficacy 
were measured.
Speight 
et al., 3338 1376 42 15.2 7.8
Community 
Sample Australia
A random sample 
registered with the 
National Diabetes 
Service Scheme 
(NDSS) who were 
contacted by mail
Not reported
Depression was mea-
sured with the PHQ-9 
with cut-off scores of 
10 and 15 for moderate 
and severe depression 
respectively. Anxiety was 
assessed with the GAD-7 
with cut-off scores of 10 
and 15 for moderate and 
severe anxiety respec-
tively. Diabetes-distress 
was also assessed with 
the PAID scale.
Table 2: Comparison of participant demographics and methods between studies.
Centre for Epidemiologic Studies Depression Scale (CES-D): Beck Depression Inventory; Composite International Diagnostic Interview (CIDI); Dose Adjustment 
for Normal Eating (DAFNE); GAD-7 (Generalised Anxiety Disorder scale); Hospital Anxiety Depression Scale (HADS); Mini International Neuropsychiatric Interview 
(MINI); Problem Areas in Diabetes (PAID); Patient Health Questionnaire (PHQ-9); World Health Organisation (WHO-5)
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Study Melin et al.,
Maia et 
al.,
van 
Bastelaar 
et al.,
Sacco 
et al.,
Bot 
et al.,
Ahola 
et al.,
Collins 
et al.,
Pouwer 
et al.,
Gendleman 
et al.,
Shaban 
et al.,
Ruddock 
et al.,
Longitudinal Design
Were participants followed up over time?           
Selection unbiased
Was selection clearly described and not 
influenced by history of mental illness 
(unless ongoing illness severe in nature)?
 Unclear     Unclear   Unclear 
Appropriately focussed sample
 Did the sample consist of Type 1DM 
only? Or was there a clear distinction in 
methods and results between Type 1 DM 
and Type 2 DM participants? or clearly 
differentiated between Type 1 DM and 
Type 2 DM
          
Relevant participant variables considered
Reported proportion of sample with diabe-
tes-related complications
          
Use of a control group
Was a control group of people without 
diabetes included?
          
Validity of scales
Were validated measures of depression 
and anxiety used?
          
Psychotropic use
Was data collected data on current 
psychotropic use at time of study and 
included in analyses?
          
Clinical psychological assessmentWas 
clinical assessment used to either assess 
psychological distress or verify the validity 
of psychological assessment scales?
          
Study Manarte & Dias,
Lloyd 
et al.,
Hirai et 
al.,
Reichel et 
al.,
Rasmussen 
et al., 
Tanebaum 
& Gonza-
lez
Hopkins 
et al.,
Aberle et 
al.,
Speight et 
al.,
Longitudinal Design
Were participants followed up over time?         
Selection unbiased
Was selection clearly described and not 
influenced by history of mental illness 
(unless ongoing illness severe in nature)?
   unclear     
Appropriately focussed sample
Did the sample consist of Type 1DM 
only? Or was there a clear distinction in 
methods and results between Type 1 DM 
and Type 2 DM participants? or clearly 
differentiated between Type 1 DM and 
Type 2 DM
        
Relevant participant variables considered
Reported proportion of sample with diabe-
tes-related complications
        
Use of a control group
Was a control group of people without 
diabetes included?
    N/A    
Validity of scales
Were validated measures of depression 
and anxiety used?
        
Psychotropic use
Was data collected data on current 
psychotropic use at time of study and 
included in analyses?
    N/A    
Clinical psychological assessment
Was clinical assessment used to either 
assess psychological distress or verify 
the validity of psychological assessment 
scales?
    N/A    
B
ia
s 
A
ss
es
sm
en
t P
ar
am
et
er
s
B
ia
s 
A
ss
es
sm
en
t P
ar
am
et
er
s
Type 1 DM: Type 1 Diabetes Mellitus; Type 2 DM: Type 2 Diabetes Mellitus
Table 3: Assessment of risk of bias.
N/A: Not Applicable; Type 1 DM: Type 1 Diabetes Mellitus; Type 2 DM: Type 2 Diabetes Mellitus
*Qualitative study
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 Most studies were cross-sectional rather than longitudinal in 
design. However, it was felt given the ample data available from the 
large number of studies in total could help balance this limitation. 
Importantly, all studies used validated measures for psychological 
assessment and all studies clearly differentiated the type of diabetes.
 Not all studies included psychotropic medication use in their 
analyses and future study designs should aim to include this variable. 
Participants who are taking psychotropic medication for the treatment 
of depression or anxiety may not score on psychological assessment 
scales and this could influence results. Some studies, however, were 
considering the effect of depressive symptoms on glycaemic control 
and in these instances it was appropriate to discount those receiving 
treatment. Moreover, it was felt that even where psychotropic 
medication use could have been relevant, these study designs were 
otherwise sound and risk of bias was relatively low and therefore 
included in this review.
 Risk of bias across studies in this review is notable, as shown by 
a relatively high degree of heterogeneity in sample size, participant 
characteristics, and psychological measures utilized between 
measures. Past studies have also commented on the need for a 
streamlined approach to measuring psychological variables in this 
population [16].
Prevalence of depression
 As shown in table 1, the reported prevalence of depression between 
studies ranged from 9% [29] to 54% [30]. Although most studies used 
self-report as a means of psychological assessment, differences in 
the specific scales chosen may have contributed to the differences in 
prevalence rates observed.
 Of the studies that used self-report the average prevalence of 
depression was 20% (range 10-54%). This is higher than previously 
reported levels by Roy et al., who found that studies without control 
groups reported prevalence of depression at 12% [10]. Gendelman et 
al., was the only study that included a control group of participants 
who did not have diabetes, and they found the prevalence of 
depression in people with Type 1 DM to be 18% and even higher if 
people taking antidepressants were added (32%) [31] - higher than the 
previously reported average prevalence of 12% in controlled studies 
[10].
 Consistent with past research [32], studies utilising interview 
methods produced lower prevalence rates of depression than 
self-report. Maia et al., for example, found that the prevalence of 
‘current depression’ in their cohort of 100 people with Type 1 DM was 
9%. This low value could be because the researchers differentiated 
current depression from past clinical depression and dysthymia. In 
addition, the fact that patients were assessed with the Mini 
International psychiatric Interview (MINI) may help explain why 
current major depression was 9% prevalence and yet overall mood 
disorder prevalence was high (67%) [29].
 The highest prevalence of depression was reported by Manarte et 
al., who used the Hamilton Score with a cut-off score of 7 and above 
to find that 54% of their sample had symptoms of depression [31]. 
This measurement tool was not used by any other study in this review 
and therefore no comparisons can be made on the basis of assessment. 
However, in their sample 75% had at least one diabetes complication 
and only 24% had ‘well controlled’ diabetes with a HbA1c below 7% 
[31]. Therefore it is possible that their sample is representative of 
people more difficult to control diabetes, and may not be applicable to 
people with no complications or good glycaemic control.
Prevalence of anxiety
 Prevalence of anxiety in participants with Type 1 DM was 25% on 
average (range 13 - 38%) (Table 4). When studies that used self-report 
measures only were compared the average was slightly higher at 27%. 
The significant variation in reported values reflects an inherent 
uncertainty within the collective literature about the overall 
prevalence of anxiety among people with Type 1 DM. Previous 
literature reviews have not assessed whether or not anxiety is higher in 
people with Type 1 DM compared to the general population [10,33], 
therefore no comparisons can be made. However, data included in 
this review demonstrates that anxiety is more common in people with 
Type 1 DM when compared to reported rates of anxiety in the general 
Australian population [34].
 These high rates seem reasonable given that depression and 
anxiety are frequently co morbid [35]. However, it was unclear 
from this review whether anxiety or depression is more commonly 
comorbid in Type 1 DM. Maia et al., found that generalized anxiety 
disorder was more common than depression with a prevalence of 24% 
[30].
 The mode of psychological assessment is an important consider-
ation when considering these results. Three studies [4,23,30] showed 
that at least one third of their sample had significant symptoms of 
anxiety. Importantly, all of these studies used the HADS measure of 
self-report, which may represent a propensity for higher scorings 
using this measure. Speight et al., used the GAD-7 as a measure of 
anxiety reported comparably lower rates of anxiety, and therefore 
it’s unclear whether this discrepancy is due to differences in sample 
population or psychological measures.
 Several factors were implicated in the risk of comorbid anxiety 
and Type 1 DM. Collins et al., found that the pressure to maintain 
glycaemic control was anxiety-provoking, as participants who 
perceived their blood sugar control as poor were more likely to 
be anxious than those who judged their control positively [4]. In 
contrast, Hopkin’s et al., found that Dose Adjustment for Normal 
Eating (DAFNE) training was associated with lower scores of anxiety 
[36]. It is therefore possible that diabetes-specific knowledge may be 
an important factor in reducing anxiety.
Glycaemic control and depression
 There were eight studies that examined the relationship between 
depression and glycaemic control.
 While some data suggest that people with comorbid depression 
may have worse glycaemic control [14,37-39], this was not a universal 
finding [31,40,41], with van Bastelaar, Pouwer et al., [5] reporting that 
participants with depression, but without diabetes-related distress, did 
not have changes to their glycaemic control. Whereas those who had 
depression as well as distress showed sub-optimal control [5]. Hence, 
having insight in to whether a patient’s distress is diabetes-related 
may be relevant to predicting impact on glycaemic control. This is in 
keeping with a recent report by Fisher et al., who recommend 
healthcare professionals understand the causes of their patient’s 
distress when creating a tailored diabetes management plan [22].
 Data also revealed that certain symptoms of depression may have 
more bearing on glycaemic control than others. For example Bot et 
al., found that sleep and appetite problems correlated with increased 
HbA1c [14]. Interestingly, although these individual symptoms of 
depression in this study were predictive of glycaemic control, 
participants’ overall scores of self-reported of depression was not [14]. 
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This could be because symptoms of sleep and appetite change may 
represent difficulties in attaining optimal blood glucose control rather 
than these symptoms representing the somatic symptoms of a 
depressive disorder.
Diabetes-related complications
 Depression was associated with diabetes complications in several 
studies [37,28,32,42-44] however there was some conflicting evidence. 
There was some data that neuropathy is more common with 
comorbid depression [44,45]. Yet whilst Melin et al., found an 
association between depression and poor glycaemic control, 
depression did not increase the risk of diabetes complications [45].
 Similarly, although Ahola et al., found that proliferative 
retinopathy was more common with comorbid depression [43] other 
studies found no association with retinopathy [31,44].
 Two literature reviews previously concluded that comorbid 
depression was associated with an increased risk of diabetes 
complications [10,33], however none have looked exclusively at data 
examining people with Type 1 DM. Therefore the effect of comorbid 
depression on the risk of diabetes complication in people with Type 1 
DM is not as clear-cut as those with Type 2 DM.
 Individual differences that mediate the effects of comorbid 
depression on diabetes management: Review of the literature revealed 
that gender, socioeconomic status and duration of diabetes can be 
important risk factors for comorbid depression [43,46]. This is 
consistent with previous literature reviews and reflected similar trends 
in the general public [42,43]. Melin et al., found depression was more 
common among females compared to males [45], and Collins et al., 
reported anxiety was more common in females [42].
 The literature also considered whether age or diabetes duration 
is important risk factor. Collins et al., found that older age was 
protective for depression in Type 1 DM, however, four other studies 
found increased age to be a risk factor for depression [31,42,43,45]. 
Similarly, previous literature review also found conflicting evidence 
for the relationship between age and depression [10].
 Diabetes-specific factors such as diabetes education are important 
to consider in terms of their impact on psychological morbidity. 
Hopkins et al., found that after delivery of a structured education 
program to people with Type 1 DM resulted in lower scores of 
depressive symptoms compared to baseline [36].
Qualitative data
 Anecdotal evidence collected by Rasmussen et al., revealed that 
participants found their blood glucose control was influenced by 
significant life events, including transitions made as part of usual 
life development and transitions related to their diabetes [47,48]. It 
was noted that aspects of living with diabetes presented with unique 
additional stressors, such as the added stress of needing to manage 
diabetes whilst pregnant, and the development of diabetes-related 
complications such as depression [47].
 Qualitative data from Tanebaum & Gonzalez, 2012 reported the 
bi-directional effects of blood glucose and mood [27]. In particular 
HbA1c results caused feelings of depression and frustration, and 
the frequently an overlap between diabetes-related and depressive 
symptoms were noted. These included change in appetite, energy 
levels and sleep disturbance, with participants reporting it was often 
hard to tell if they were experiencing difficulty concentrating or 
sleeping because of fluctuations in their blood glucose or because 
of their mood. Furthermore the presence of low mood and anxiety 
caused further concern in some participants who worried that 
psychological stress would negatively impact on their glycaemic 
control [27].
Summary and Recommendations
 This review aimed to identify and assess relevant articles that 
considered the prevalence of depression and anxiety among people 
living with Type 1 DM, and/or examined factors that may contribute 
to this comorbidity and the complications that can occur. An 
extensive literature search identified twenty-one key articles which 
were reviewed to provide strong evidence further supporting the 
notion that there is increased prevalence of comorbid depression and 
anxiety in Type 1 DM.
 Based on the literature reviewed, our article shows that up to two 
in five people living with Type 1 DM suffer from comorbid clinical 
depression, and one in four experience anxiety. There was variation 
in the exact rates reported between articles, however, which may be 
reflective of differences in methods or samples. Past research has 
also noted the significant heterogeneity of methods in research of 
depression in diabetes, highlighting a need for the streamlining of 
psychological assessment to allow for more accurate comparisons and 
stronger conclusions to be drawn [22].
Study Sample size Measure of anxiety Total with anxiety (%)
Men with anxiety 
(% of men)
Women with anxiety 
(% of women)
Melin et al., 292 HADS score ≥ 8 101 (35%) 40 (25%)* 61 (47%)*
Maia et al., 100 with T1 DM (200 total) MINI; generalised anxiety disorder 24 (24%) - -
Collins et al., 296 with T1 DM (1456 total) HADS score ≥ 8 96 (33%) 54 (31%) 42 (45%)
Ruddock et al., 111 with T1 DM (211 total) HADS score ≥ 8 42 (37%)‡ - -
Grant et al., 225 with T1 DM; non pump group (775 total) Medical records and psychotropic use - 13% - -
Hopkins et al., 484 HADS score ≥ 8 baseline (24%)α - -
  HADS ≥ 8 after DAFNE education (18%)α - -
Speight et al., 1376 with T1 DM (3338 total) GAD - 7 - 15% - -
Table 4: Prevalence of anxiety in adults with type 1 diabetes mellitus.
Generalised Anxiety Disorder scale (GAD-7); Hospital Anxiety Depression Scale (HADS); Mini International Neuropsychiatric Interview (MINI)
*p<0.05
‡Ruddock et al., reported that women with Type 1 DM were twice as likely to have anxiety symptoms than men
αHopkins et al., found a significant improvement in HADS score for depression after DAFNE education programs compared to baseline levels
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 In addition only seven articles measured levels of anxiety in their 
participants, and little is still known about complications associated 
with comorbid anxiety in Type 1 DM. Past reviews have also 
neglected to consider comorbid anxiety [10,33] so it’s not possible to 
make comparisons. More research in to the nature of anxiety in people 
with Type 1 DM is warranted, especially given that depression and 
anxiety are usually co-occurring.
 The large prevalence of anxiety and depression amongst people 
living with Type 1 DM has significant implications for a person’s 
psychological well-being, overall physical health, their diabetes care 
and general quality of life. For these reasons it is important to consider 
how evidence from these studies can inform practice. Research has 
shown that it is possible to effectively screen for depression in a 
primary care and specialist settings using simple and time-efficient 
two-stem questions [10]. However, given that time constraints are 
common in the clinical setting, it’s important that specific risk factors 
are identified so that screening may be targeted to people at greatest 
risk. Review of the literature found that risk factors for the 
development of depression in people with Type 1 DM largely 
reflected the risk factors same as for the general population, such as 
female gender and lower socioeconomic status. Diabetes-specific risk 
factors were also found, including low self-efficacy regarding diabetes 
management and perceived poor glycaemic control. Therefore, 
people who have low levels of education, poor health literacy, 
sub-optimal glycaemic control and a history of depression and 
anxiety should screened on a regular basis for diabetes-distress, 
clinical depression and anxiety disorders.
 Whilst screening is crucial, it is important for healthcare workers 
to have a deeper understanding of the lived experiences of people with 
Type 1 DM [22,27]. Having insight in to diabetes and non-diabetes 
stressors provides important context for the assessment and 
management of depression and anxiety, and can improve pa-
tient-physician relationships which can in turn result in improved 
communication and adherence [20]. This insight can be gained with 
clinical experience, good communication with patients, and with 
information gathered from qualitative studies. However, there were 
only two studies identified in this review that were qualitative, and 
most of the remaining studies relied on self-report measures.
 Understanding the lived experience of Type 1 DM is also 
important for the delivery of tailored psych education, specific to 
depression and anxiety in the context of Type 1 DM. The importance 
of psych education specific to people living with Type 1 DM has been 
highlighted in other studies [18,22], but is an area of research that 
requires more investigation.
Limitations
 Despite an extensive and systematic literature search this study 
has a number of limitations. Firstly, the papers identified were mainly 
observational studies, and it is therefore not possible to draw 
conclusions about the direction of the relationship between 
Type 1 DM and depression. Although this review did not identify 
much evidence on the biological aspects of diabetes as a risk factor 
for the pathogenesis of depression, it is likely that a bidirectional 
relationship exists.
 Secondly, the assessment of depression in the studies was often 
by self-report, which may not reflect true diagnoses of depressive 
illnesses. It has been found that compared to diagnostic interview, 
self-report measures of depression may over-estimate the prevalence 
of depression [3,32]. Although self-report is an efficient and 
cost-effective method of assessment, diagnostic interview would 
increase the validity of results.
 Thirdly, there was significant heterogeneity in both the methods 
and samples between studies. This made it difficult to make accurate 
comparisons between the results. Consensus within the literature 
on tools for assessing psychological distress within this population 
is needed. Ideally assessment would reconcile diabetes-distress with 
symptoms of depression and anxiety. Nevertheless, the diversity of 
samples studied also provides robustness to the collective evidence, 
as it demonstrates that the observation of increased depression and 
anxiety in people living with Type 1 DM is a phenomenon observed 
across a range of demographics.
 Furthermore the literature search was limited to articles published 
in English. Many of these studies were conducted overseas which may 
limit the degree to which these results can be generalized to our local 
population. It would be invaluable to have some research conducted 
within Australia to see if there are population-specific variables that 
need to be taken in to account.
Conclusion
 The pertinence of the evidence analyzed in this review is 
underpinned by findings from large international studies that have 
shown depression results in worse health outcomes for individuals 
compared to any other chronic disease, including diabetes [6]. 
Further, the combination of depression and diabetes leads to even 
poorer outcomes than does the combination of diabetes and other 
chronic diseases. Therefore for people living with Type 1 DM, 
depression and anxiety are potentially the largest impediments to 
attaining optimal health and overall quality of life.
 This review has provided evidence to support the finding that 
depression and anxiety are more common in people with Type 1 DM 
and that it is under-diagnosed and undertreated.
 Ongoing research in this area will allow for the development 
of tailored screening tools or assessment guidelines that can help 
to improve diagnosis of psychological disorders in Type 1 DM. 
Future research will also allow for the development of structured, 
evidence-based interventions to reduce psychological morbidity in 
this group and ultimately improve overall patient care.
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